COMMUNIQUÉS West-GlobeNewswire

Applied Biologics Publishes New Translational Research Demonstrating Ligament Regeneration with XWRAP®-Based Biologic Augmentation
30/09/2026
Preclinical orthopedic study demonstrates progressive restoration of native-like collagen architecture, supporting continued investigation of XWRAP in surgical and sports medicine applications SCOTTSDALE, Ariz., Sept. [...]
Legend Senior Living Associate Stephanie Vacanti Honored as 2026 TALA Hero Award Recipient
30/09/2026
MANSFIELD, Texas, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Stephanie Vacanti, Health Care Director at Legend of Mansfield, has been recognized by the Texas Assisted Living Association (TALA) as a 2026 TALA Hero Award [...]
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
30/09/2026
Fontaine Vitale represents a significant new market and revenue opportunity for Celularity in the Asia-Pacific region FLORHAM PARK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” [...]
Two Lipidomics Excellence Awards Led to Two Major Publications
30/09/2026
Two recipients of Lipotype's Lipidomics Excellence Award have published award-supported lipid research at major scientific publications DRESDEN, Germany, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Lipotype introduced the [...]
SK pharmteco annonce un investissement de plus de 200 millions de dollars aux États-Unis pour renforcer ses capacités de production de petites molécules et de peptides
30/09/2026
RANCHO CORDOVA, Californie, 30 sept. 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui un plan d’investissement global de plus de 200 millions de dollars sur cinq ans destiné à étendre et à moderniser ses [...]
Flame Diet App Launches Personalized Anti-Inflammatory Diet
30/09/2026
Flame Diet App Turns a Short Quiz Into an Anti-Inflammatory Meal Plan and Light Workout Routine NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Flame Diet has launched a personalized anti-inflammatory diet and wellness app [...]
UPDATE – Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
30/09/2026
EVENT UPDATE: Due to the flood watch in effect and the potential for severe weather, this event will be postponed . Please stay safe and keep an eye out for an updated date and time. The original release follows: CEDAR [...]
Native Path Collagen 2026: Launch Effective NativePath Collagen Peptides Dark Spots Bruising & Support for Skin, Hair, Joints & Bones Supplement Facts
30/09/2026
NativePath Collagen Peptides, a hydrolyzed Type I and III collagen supplement made from grass-fed bovine sources. Learn about its ingredients, formulation, and how collagen peptides are designed to complement daily [...]
Peptides Canada, Operated by Growth Guys, Announces Research-Use Peptide Supply Services for Canadian Laboratories
30/09/2026
TORONTO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Peptides Canada has announced the availability of research-use peptide materials through its online platform, providing Canadian laboratories and researchers with access to [...]
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
30/09/2026
Silver Spring, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its [...]
Inteleos Earns UN ECOSOC Status to Advance Quality Care Worldwide
30/09/2026
Special Consultative Status expands Inteleos’ ability to build health equity through global partners and policy ROCKVILLE, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The United Nations Economic and Social Council (ECOSOC) [...]
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
30/09/2026
NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced it will [...]
SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
30/09/2026
RANCHO CORDOVA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a comprehensive five-year, more than $200 million investment plan to expand and upgrade its U.S. development and manufacturing [...]
ALK expands strategic tablet supply partnership with Catalent
30/09/2026
Inside Information Agreement provides long-term expanded access to Catalent's fast-dissolving (Zydis ® ) tablet formulation technology. Supply robustness secured with prioritised manufacturing capacity increase of ~40% [...]
CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery
30/09/2026
PHACT™ CB0104A earned BPI Commercial and Home Compostable, TÜV AUSTRIA OK compost HOME & OK compost INDUSTRIAL Certifications New all-PHA compound is designed for cutlery, caps, enclosures, beauty packaging, and [...]
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
30/09/2026
- Recently awarded patents have solidified Allarity’s strategy to leverage DRP to ensure the commercial exclusivity of stenoparib TARPON SPRINGS, Fla., September 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the [...]
Hyperion DeFi, Anchorage Digital, and HyperLend Together Announce the First Institutional Credit Facility on Hyperliquid
30/09/2026
Institutional Credit Layer on HyperEVM Secured by Collateral in Qualified Custody at a Federally Chartered Bank DALLAS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “ [...]
HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
30/09/2026
DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in [...]
Highlight Therapeutics Presents Positive Phase 2b Topline Results of Intralesional BO-112 in Localized Basal Cell Carcinoma as a Late-Breaker at EADV
30/09/2026
Primary composite endpoint met: 61% of patients achieved visual and pathological response across all treated lesions. Complete clinical and pathological response in 56% of high-risk head & neck patients and 62% of [...]

Pages